The FDA has approved SciBase AB's Nevisense 3.0, the third generation of their Nevisense system for early melanoma detection. Nevisense, an AI-based...
Medical aesthetics company Cynosure has secured approval from the US Food and Drug Administration (FDA) for its Potenza radiofrequency (RF) microneedling device.
Revance Therapeutics, Inc. (Nasdaq: RVNC), a biotechnology pioneer focused on innovative aesthetic and therapeutic offerings, including its next-generation neuromodulator product, DaxibotulinumtoxinA for Injection...
2019 was an
exciting year for Medical Aesthetics, a year of cosmetic self-reflection focused
on selfies and social media, driven by controversies around buttock
augmentation...
Lutronic has received FDA clearance of the Lutronic Genius™ platform for radiofrequency microneedling. The company says the device transmits energy more precisely into...
---- The dual-effect Hybrid Injectable contains two active ingredients, hyaluronic acid (HA) - a well-known ingredient found in facial fillers1 - and calcium hydroxyapatite...
Alma TED, an Ultrasound-based system with a propriety Tip engineered with Impact Delivery™, offers a non-invasive, non-traumatic option to address the market's...
After several promising early phase studies, an injectable hyaluronic gel has been associated with sustained improvements in the appearance of the jaw...